Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
719.57Price to Book
VS
Market
Sector
Industry
History
$ 0.69Close
$ 0.66 - $ 9.16 52-Week Range
Ticker Information
Ticker
CURXCompany Name
CURANEX PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCURANEX PHARMACEUTICALS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CURX - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 305.43K | $ 219.78M | 719.57 |
| 3/31/2025 | $ 365.78K | $ 0 | 0 |
| 12/31/2024 | $ 503.36K | $ 0 | 0 |
| 9/30/2024 | $ 640.52K | $ 0 | 0 |
| 12/31/2023 | $ 60.09K | $ 0 | 0 |
Key Performance Insights, Last 5 Years
- CURANEX PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/B stands at 0.
- Over the past 5 years, CURANEX PHARMACEUTICALS INC's average P/B has been 719.57.
- The median P/B for CURANEX PHARMACEUTICALS INC during this period was 719.57
- CURANEX PHARMACEUTICALS INC reached its highest P/B over the past 5 years at 719.57.
- The lowest P/B recorded by CURANEX PHARMACEUTICALS INC in the same timeframe 719.57
CURANEX PHARMACEUTICALS INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for CURANEX PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 0 ] / Equity [ $ 60.09K ]
(=) P/B [ 0 ] CURX - Price to Book, Last 5 years
719.57
Minimum
Jun 30, 2025
719.57
Maximum
Jun 30, 2025
719.57
Average
719.57
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |